Understanding Your Biopsy and Blood Work
At a Glance
Livedoid Vasculopathy is diagnosed using a deep skin biopsy to detect blood vessel clots and blood tests to identify underlying clotting disorders. A biopsy showing clots without severe inflammation confirms the condition, even if your blood work comes back completely normal.
To confirm a diagnosis of Livedoid Vasculopathy (LV) and distinguish it from other conditions, doctors rely on two main tools: a skin biopsy to look at the structure of your tissue, and blood work to search for underlying triggers. Understanding these reports can help you advocate for the most accurate diagnosis and treatment plan.
Decoding Your Biopsy Report
A biopsy is a procedure where a small piece of skin is removed for examination under a microscope. For LV, doctors typically perform a deep punch biopsy (usually 4–6mm deep) [1]. It is best taken from the edge of an active, painful ulcer or a new purple spot, rather than the center of an old scar [2].
When you read your pathology report, look for these key technical terms that signal LV:
- Intraluminal Thrombosis: This means “clots inside the vessel.” It is the most important finding in LV and shows that fibrin (a clotting protein) is blocking the blood flow [3][1].
- Hyaline Degeneration: This describes a “glassy” or thickened appearance of the blood vessel walls [1]. Reports may specifically mention it is PAS-positive, which refers to a special stain used to make these deposits visible [3][4].
- Endothelial Proliferation: This means the cells lining your blood vessels are growing or “plumping up,” which can further narrow the space for blood to flow [1][2].
Why Biopsy Matters
The biopsy is the primary way doctors rule out “true” vasculitis. If the report shows these clotting features but does not show a heavy attack by white blood cells (neutrophils), it confirms that your condition is a vasculopathy (clotting problem) rather than an inflammatory one [1][5].
The Blood Work Checklist
While the biopsy confirms what is happening in your skin, blood work helps determine why it is happening. LV is often linked to thrombophilia—a tendency for the blood to clot too easily [6][7].
You may want to ensure your care team has screened for the following factors:
1. Clotting (Thrombophilia) Panel
- Factor V Leiden & Prothrombin Gene Mutation: Genetic markers that increase clot risk [6].
- Protein C, Protein S, & Antithrombin III: Natural “anticoagulants” in your body; if these are low, you may clot more easily [6].
- Homocysteine & Lipoprotein(a): High levels of these can irritate blood vessels and promote clotting [7][6].
(Tip: Because full thrombophilia panels require drawing a significant number of blood vials, stay well-hydrated before your lab visit).
2. Autoimmune & Inflammatory Markers
- Antiphospholipid Antibodies: Includes Lupus Anticoagulant and Anticardiolipin antibodies, which are common triggers for vessel blockage [6].
- ANA (Antinuclear Antibody): A general screen for connective tissue diseases like Lupus, which can occur alongside LV [8][9].
3. Rare or Specialized Tests
- ADA2 (DADA2): A genetic test for a rare condition that can mimic LV symptoms [6].
- Direct Immunofluorescence (DIF): A special test on a skin biopsy that looks for immune deposits (like IgM or C3) in the vessel walls to help distinguish LV from other conditions [10].
Identifying Lifestyle Triggers
Certain everyday lifestyle factors and medications can significantly increase your blood’s tendency to clot, making LV symptoms worse. You should discuss the following with your doctor:
- Smoking: Smoking causes profound vasoconstriction and increases clot risk.
- Hormones: Estrogen-based medications, including certain birth control pills or hormone replacement therapy (HRT), are known to increase thrombosis risk and may need to be adjusted or stopped.
What if My Results Are “Normal”?
It is important to know that many patients with LV have completely normal blood work [7][11]. This is sometimes called “idiopathic” LV. A normal lab result does not mean you don’t have the condition; it simply means your specific trigger may not be captured by current standard tests [7]. Your diagnosis is primarily based on your symptoms and what the doctor sees in the biopsy [2][12].
Common questions in this guide
What does a biopsy for Livedoid Vasculopathy look for?
Where should the skin biopsy be taken from?
Why do I need blood work if the biopsy confirms Livedoid Vasculopathy?
Can I still have Livedoid Vasculopathy if my blood tests are normal?
How does Livedoid Vasculopathy differ from vasculitis on a biopsy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my biopsy report mention 'PAS-positive' material or 'intraluminal fibrin'?
- 2.Was the biopsy taken deep enough to see the small vessels in the dermis?
- 3.Are there any specific blood tests from the 'thrombophilia panel' that we haven't ordered yet?
- 4.How should I prepare for these blood tests—should I stop any medications (like aspirin) beforehand?
- 5.If my blood work comes back 'normal,' does that rule out Livedoid Vasculopathy, or can I still have the condition?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Livedoid vasculopathy: how to diagnose and how to treat?
Lipsker D
Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(9)):1627-1628 doi:10.1111/jdv.15830.
PMID: 31468610 - 2
Characteristics, risk factors and treatment reality in livedoid vasculopathy - a multicentre analysis.
Weishaupt C, Strölin A, Kahle B, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(9)):1784-1791 doi:10.1111/jdv.15639.
PMID: 31009111 - 3
Lymphocytic vasculitis in livedoid vasculopathy: A report of 137 cases.
Yuan Y, Liu Y, Ban F, et al.
Journal of cutaneous pathology 2024; (51(2)):155-162 doi:10.1111/cup.14546.
PMID: 37837185 - 4
Penile Livedoid Vasculopathy: First Reported Case.
Hallak A, Bennett W, Tanbir MA, et al.
Case reports in vascular medicine 2023; (2023()):6920383 doi:10.1155/2023/6920383.
PMID: 37440957 - 5
Inflammatory and vaso-occlusive ulcers: Part I - Clinical presentation and diagnosis.
Shakshouk H, Hines A, Kody S, et al.
Journal of the American Academy of Dermatology 2024; (91(6)):1035-1048 doi:10.1016/j.jaad.2024.01.083.
PMID: 38432459 - 6
Livedoid vasculopathy in 75 Brazilian patients in a single-center institution: Clinical, histopathological and therapy evaluation.
Criado PR, Pagliari C, Morita TCAB, et al.
Dermatologic therapy 2021; (34(2)):e14810 doi:10.1111/dth.14810.
PMID: 33496999 - 7
Livedoid vasculopathy: does hyperhomocysteinaemia play an aetiological role?
Marsch WC, Komatsuzaki S, Mueller A, et al.
European journal of dermatology : EJD 2019; (29(3)):287-293 doi:10.1684/ejd.2019.3554.
PMID: 31389788 - 8
Prevalence of Livedoid Vasculopathy Among Patients with Connective Tissue Diseases and Its Association with Thrombophilic Factors: A Hospital-Based Retrospective Cohort (2014-2021).
Argobi Y
Clinical, cosmetic and investigational dermatology 2025; (18()):2971-2977 doi:10.2147/CCID.S551007.
PMID: 41234949 - 9
Systemic lupus erythematosus with refractory ulcerated livedoid vasculopathy: Successful treatment with intravenous immunoglobulin and warfarin.
Yoshioka K, Tateishi C, Kato H, Chen KR
Clinical case reports 2018; (6(11)):2045-2047 doi:10.1002/ccr3.1803.
PMID: 30455888 - 10
Direct immunofluorescence findings in livedoid vasculopathy: a 10-year study and literature review.
Nuttawong S, Chularojanamontri L, Trakanwittayarak S, et al.
Clinical and experimental dermatology 2021; (46(3)):525-531 doi:10.1111/ced.14464.
PMID: 32986882 - 11
Successful treatment of livedoid vasculopathy with rivaroxaban.
Evans JM, Jensen JD, Sami N
JAAD case reports 2015; (1(6)):340-1 doi:10.1016/j.jdcr.2015.08.002.
PMID: 27051773 - 12
Livedoid vasculopathy, calciphylaxis, and Martorell's hypertensive ulcer: update on ischemic ulcers due to impaired microcirculation of the lower limbs.
Lacerda PN, Garcia LC, Mazeto IFDS, et al.
Anais brasileiros de dermatologia 2025; (100(2)):215-227 doi:10.1016/j.abd.2024.09.004.
PMID: 39848831
This page explains Livedoid Vasculopathy biopsy and blood test terminology for educational purposes. Your dermatologist or hematologist is the best source for interpreting your specific pathology reports and lab results.
Get notified when new evidence is published on Livedoid vasculopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.